Literature DB >> 2684227

Glomerular hemodynamics in pathophysiologic conditions.

R C Blantz1, F B Gabbai.   

Abstract

Under normal conditions glomerular blood flow and glomerular capillary hydrostatic pressure and hydrostatic pressure gradient are regulated within a narrow range in spite of variations in volume status and blood pressure. Glomerular ultrafiltration rate is normally regulated by the hydrostatic pressure gradient, the systemic oncotic pressure, the rate of nephron plasma flow and the glomerular ultrafiltration coefficient. Although the process of glomerular ultrafiltration is driven by the hydrostatic pressure gradient (delta P), regulation of nephron filtration rate (SNGFR) is not mediated by changes in hydrostatic pressure and the correlation between SNGFR and delta P is very poor. There are certain clinical experimental models in which the glomerular capillary hydrostatic pressure gradient is elevated. These models have been: (1) subtotal nephrectomy model, a model of reduced renal mass, (2) glomerular immune induced injury or glomerulonephritis, (3) most models of systemic hypertension, and (4) certain stages of experimental diabetes mellitus, but the mechanisms vary among the conditions. In most of these clinical models the increase in delta P is associated with a reduction in the glomerular ultrafiltration coefficient. It is also clear that superimposition of hypertension upon models of glomerular immune injury and radical subtotal nephrectomy cause progression of renal dysfunction and glomerulosclerosis. One of the contributing factors to this progression appears to be the elevation in glomerular capillary hydrostatic pressure and pressure gradient. However, other factors have been suggested to play a significant role, such as compensatory hypertrophy and possibly the neurohumoral environment. Therapy of systemic hypertension and administration of cardiovascular drugs which alter glomerular capillary hydrostatic pressure may then modify the rate of progresswion of these disorders.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1989        PMID: 2684227     DOI: 10.1093/ajh/2.11.208s

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  8 in total

1.  Comparison of the Pharmacokinetic Profiles of Ceftriaxone Used Alone and Combined with Danhong Injection in Old Rats.

Authors:  Qian Zhang; Jianming Guo; Guoliang Dai; Jianping Li; Lijing Zhu; Shufen He; Yang Zong; Zhishu Tang; Buchang Zhao; Wenzheng Ju; Jinao Duan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2019-08       Impact factor: 2.441

2.  eNOS deficiency acts through endothelin to aggravate sFlt-1-induced pre-eclampsia-like phenotype.

Authors:  Feng Li; John R Hagaman; Hyung-Suk Kim; Nobuyo Maeda; J Charles Jennette; James E Faber; S Ananth Karumanchi; Oliver Smithies; Nobuyuki Takahashi
Journal:  J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 10.121

Review 3.  Glomerular function reserve and sodium sensitivity.

Authors:  Genjiro Kimura
Journal:  Clin Exp Nephrol       Date:  2005-06       Impact factor: 2.801

Review 4.  Assessment of nephron number and single-nephron glomerular filtration rate in a clinical setting.

Authors:  Nobuo Tsuboi; Takaya Sasaki; Yusuke Okabayashi; Kotaro Haruhara; Go Kanzaki; Takashi Yokoo
Journal:  Hypertens Res       Date:  2021-02-01       Impact factor: 3.872

5.  Hyperglycemia and renal mass ablation synergistically augment albuminuria in the diabetic subtotally nephrectomized rat: implications for modeling diabetic nephropathy.

Authors:  Li-Hao Chen; Bailey Stead; Suzanne L Advani; Noreen Yaqoob; Kerri Thai; M Golam Kabir; Darren A Yuen; Kim A Connelly; Richard E Gilbert; Andrew Advani
Journal:  Nephron Extra       Date:  2012-05-12

6.  Estimation of the relationship between the polymorphisms of selected genes: ACE, AGTR1, TGFβ1 and GNB3 with the occurrence of primary vesicoureteral reflux.

Authors:  Marcin Życzkowski; Joanna Żywiec; Krzysztof Nowakowski; Andrzej Paradysz; Władyslaw Grzeszczak; Janusz Gumprecht
Journal:  Int Urol Nephrol       Date:  2016-12-17       Impact factor: 2.370

7.  Follow-up after neonatal heart disease repair: watch out for chronic kidney disease and hypertension!

Authors:  Louis Huynh; Sara Rodriguez-Lopez; Kelly Benisty; Adrian Dancea; Daniel Garros; Erin Hessey; Ari Joffe; Rachel Joffe; Andrew Mackie; Ana Palijan; Alex Paun; Michael Pizzi; Michael Zappitelli; Catherine Morgan
Journal:  Pediatr Nephrol       Date:  2020-06-04       Impact factor: 3.714

Review 8.  Chronic kidney disease in congenital heart disease patients: a narrative review of evidence.

Authors:  Catherine Morgan; Mohammed Al-Aklabi; Gonzalo Garcia Guerra
Journal:  Can J Kidney Health Dis       Date:  2015-08-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.